Skip to main content
Top
Published in: Internal and Emergency Medicine 5/2023

Open Access 03-06-2023 | Celiac Disease | IM - ORIGINAL

Evolution of bone densitometry parameters and risk of fracture in coeliac disease: a 10-year perspective

Authors: Francesco Tovoli, Dante Pio Pallotta, Alice Giamperoli, Guido Zavatta, Kinga Skoracka, Alberto Raiteri, Chiara Faggiano, Iwona Krela-Kaźmierczak, Alessandro Granito

Published in: Internal and Emergency Medicine | Issue 5/2023

Login to get access

Abstract

Background

Metabolic bone disease is frequently found in patients with coeliac disease (CD). Despite its high prevalence, international guidelines are partially discordant about its management due to the lack of long-term data.

Methods

We retrospectively evaluated a large dataset of prospectively collected data of CD patients assessing the variation of DXA parameters and estimated fracture risk according to the FRAX® score in a 10-year follow-up. Incident fractures are reported, and the predictive ability of the FRAX® score is verified.

Results

We identified 107 patients with low bone density (BMD) at the diagnosis of CD and a 10-year follow-up. After improving at the first follow-up, T-scores slowly reduced over time but with no clinically relevant differences between the first and last examination (lumbar spine: from − 2.07 to − 2.07, p = 1.000; femoral neck: from − 1.37 to − 1.55, p = 0.006). Patients with osteoporosis at the index measurement had more marked fluctuations than those with osteopenia; the latter group also showed minimal modifications of the FRAX® score over time. Six incident major fragility fractures occurred, with a good predictive ability of the FRAX® (AUC 0.826).

Conclusion

Adult CD patients with osteopenia and no risk factors had substantially stable DXA parameters and fracture risk during a 10-year follow-up. A dilated interval between follow-up DXA for these patients could be considered to reduce diagnosis-related time and costs, maintaining a 2-year interval for patients with osteoporosis or risk factors.
Appendix
Available only for authorised users
Literature
10.
go back to reference Ciacci C, Maurelli L, Klain M et al (1997) Effects of dietary treatment on bone mineral density in adults with celiac disease: factors predicting response. Am J Gastroenterol 92:992–996PubMed Ciacci C, Maurelli L, Klain M et al (1997) Effects of dietary treatment on bone mineral density in adults with celiac disease: factors predicting response. Am J Gastroenterol 92:992–996PubMed
11.
go back to reference Mautalen C, González D, Mazure R et al (1997) Effect of treatment on bone mass, mineral metabolism, and body composition in untreated celiac disease patients. Am J Gastroenterol 92:313–318PubMed Mautalen C, González D, Mazure R et al (1997) Effect of treatment on bone mass, mineral metabolism, and body composition in untreated celiac disease patients. Am J Gastroenterol 92:313–318PubMed
23.
go back to reference WHO Scientific Group on the Prevention and Management of Osteoporosis (2000) : Geneva S (2003) Prevention and management of osteoporosis : report of a WHO scientific group. World Health Organization WHO Scientific Group on the Prevention and Management of Osteoporosis (2000) : Geneva S (2003) Prevention and management of osteoporosis : report of a WHO scientific group. World Health Organization
Metadata
Title
Evolution of bone densitometry parameters and risk of fracture in coeliac disease: a 10-year perspective
Authors
Francesco Tovoli
Dante Pio Pallotta
Alice Giamperoli
Guido Zavatta
Kinga Skoracka
Alberto Raiteri
Chiara Faggiano
Iwona Krela-Kaźmierczak
Alessandro Granito
Publication date
03-06-2023
Publisher
Springer International Publishing
Published in
Internal and Emergency Medicine / Issue 5/2023
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-023-03307-7

Other articles of this Issue 5/2023

Internal and Emergency Medicine 5/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.